Variability in the extent of del(5q) and its clinical implication in myelodysplastic syndromes (MDS).

被引：0
|
作者：
Zemanova, Zuzana
Brezinova, Jana
Svobodova, Karla
Lhotska, Halka
Izakova, Silvia
Sarova, Iveta
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e19025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19025
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Variability in the size of del(5q) and its clinical implication in myelodysplastic syndromes (MDS)
    Zemanova, Zuzana
    Sejgunovova, Nikola
    Svobodova, Karla
    Lhotska, Halka
    Vidlakova, Denisa
    Aghova, Tatiana
    Lizcova, Libuse
    Izakova, Silvia
    Mendlikova, Iveta
    Ransdorfova, Sarka
    Hodanova, Lucie
    Pavlistova, Lenka
    Belickova, Monika
    Brezinova, Jana
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 559 - 560
  • [2] Variability in the extent of del(5q) in myelodysplastic syndromes (MDS)
    Zemanova, Zuzana
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Vesela, Denisa
    Belickova, Monika
    Vesela, Jitka
    Izakova, Silvia
    Sarova, Iveta
    Lizcova, Libuse
    Ransdorfova, Sarka
    Pavlistova, Lenka
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    Michalova, Kyra
    MOLECULAR CYTOGENETICS, 2019, 12
  • [3] Survival of patients with de novo myelodysplastic syndromes (MDS) and del(5q)
    Gritsaev, S.
    Martinkevitch, I.
    Petrova, E.
    Kostroma, I.
    Ivanova, M.
    Sergeev, A.
    Tiranova, S.
    Potichonova, N.
    LEUKEMIA RESEARCH, 2013, 37 : S88 - S88
  • [4] CYTOGENETIC CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES (MDS) WITH ISOLATED DEL(5Q)
    Zemanova, Z.
    Michalova, K.
    Brezinova, J.
    Svobodova, K.
    Lhotska, H.
    Sarova, I.
    Lizcova, L.
    Izakova, S.
    Ransdorfova, S.
    Pavlistova, L.
    Berkova, A.
    Skipalova, K.
    Belickova, M.
    Siskova, M.
    Neuwirtova, R.
    Cermak, J.
    Stopka, T.
    Jonasova, A.
    LEUKEMIA RESEARCH, 2017, 55 : S56 - S57
  • [5] Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
    Giagounidis, Aristoteles A. N.
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 312 - 322
  • [6] Frequency and Clinical Impact of Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5q)
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Sarova, Iveta
    Lizcova, Libuse
    Izakova, Silvia
    Ransdorfova, Sarka
    Pavlistova, Lenka
    Berkova, Adela
    Skipalova, Karolina
    Belickova, Monika
    Siskova, Magda
    Neuwirtova, Radana
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    BLOOD, 2016, 128 (22)
  • [7] Atypical deletion of 5q in myelodysplastic syndromes (MDS)
    Zemanova, Z.
    Brezinova, J.
    Svobodova, K.
    Lhotska, H.
    Izakova, S.
    Lizcova, L.
    Vesela, D.
    Ransdorfova, S.
    Mendlikova, I.
    Michalova, K.
    Cermak, J.
    Jonasova, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 510 - 510
  • [8] Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Capodanno, Isabella
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (06) : 860 - 869
  • [9] Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond
    Talati, Chetasi
    Sallman, David
    List, Alan
    SEMINARS IN HEMATOLOGY, 2017, 54 (03) : 159 - 166
  • [10] Cytogenetics of myelodysplastic syndromes and detection of del 5q
    Mufti, G.
    LEUKEMIA RESEARCH, 2007, 31 : S8 - S9
12345